Arrowhead Pharmaceuticals
ARWR
#2214
Rank
A$12.26 B
Marketcap
A$87.06
Share price
-1.20%
Change (1 day)
54.63%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2026 (TTM): -A$0.23 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are A$0.66 Billion. In 2025 the company made an earning of A$0.49 Billion, an increase over its 2024 earnings that were of -A$0.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.23 Billion-145.35%
2025 A$0.49 B-157.5%
2024 -A$0.87 Billion112.45%
2023 -A$0.41 Billion87.79%
2022 -A$0.22 Billion-20.1%
2021 -A$0.27 Billion67.59%
2020 -A$0.17 Billion-347.53%
2019 A$65.05 M-245.59%
2018 -A$44.69 Million-13.17%
2017 -A$51.47 Million-52.28%
2016 -A$0.11 Billion-16.57%
2015 -A$0.13 Billion30.32%
2014 -A$99.2 Million171.62%
2013 -A$36.53 Million16.56%
2012 -A$31.34 Million107.53%
2011 -A$15.1 Million
2008 -A$53.19 Million-8.07%
2007 -A$57.85 Million70.37%
2006 -A$33.96 Million122.51%
2005 -A$15.26 Million147.41%
2004 -A$6.17 Million2002.28%
2003 -A$0.3 Million-85.61%
2002 -A$2.04 Million1371.97%
2001 -A$0.14 Million-13.45%
2000 -A$0.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.56 B-16,534.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.37 Billion 1,809.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.34 B-253.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.61 B-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-A$0.12 Billion-48.39%๐Ÿ‡บ๐Ÿ‡ธ USA